Loading organizations...
§ Venture Capital · Sweden
Venture capital firm investing in early-stage deep tech and life science companies, focused on tech and healthcare.
Key people at Fåhraeus Startup and Growth.
Fåhraeus Startup and Growth is a venture capital firm based in Lund, Sweden, that invests in early-stage deep tech and life science companies operating at the intersection of technology and healthcare. The firm manages multiple investment vehicles, recently closing its second institutional fund at €74 million in 2024, representing a significant increase from its inaugural €26 million fund. It receives backing from limited partners such as the European Investment Fund, which committed €20 million to the recent vehicle, and allocates capital to portfolio companies like Oncorena. The firm supports early-stage Nordic and European startups by drawing on operational experience from building established healthcare and technology businesses, including CellaVision and EQL Pharma. Evolving from the predecessor family office Fårö Capital which originated in 2000, Fåhraeus Startup and Growth was founded by Christer Fåhraeus and Emanuel Stihl.
Key people at Fåhraeus Startup and Growth.
Fåhraeus Startup and Growth is a venture capital fund dedicated to early-stage investments in life science and technology startups, particularly those innovating in diagnostics and pharmaceuticals. Their mission centers on empowering startups that develop groundbreaking solutions with positive societal impact. The fund combines deep operational experience and investment expertise to support companies with high growth potential, leveraging a strong industry network to accelerate their development and sustainability focus[1][2][3].
Founded in 2021 by Christer Fåhraeus and Emanuel Eriksson, the fund evolved from Christer Fåhraeus’ earlier investment firm, Fårö Capital, established in 2000. Drawing on two decades of industry insight, the team created Fåhraeus Startup and Growth to specifically back early-stage deep tech and life science ventures in the Nordic region. The fund emphasizes hands-on involvement and sustainability, adapting its investment approach as standards evolve[2][3].
Fåhraeus Startup and Growth rides the global trend of increasing demand for innovative healthcare solutions and deep tech advancements. The timing aligns with rising investments in diagnostics and pharma innovation, driven by technological breakthroughs and societal needs for better health outcomes. By focusing on sustainability and early-stage companies, the fund helps shape the Nordic startup ecosystem, fostering innovation that can scale globally[1][2][3].
Looking ahead, Fåhraeus Startup and Growth is poised to expand its influence by continuing to back transformative startups in life sciences and tech, leveraging its strong network and operational expertise. Trends such as personalized medicine, digital diagnostics, and sustainable biotech will likely shape its investment focus. As the fund grows, its role as a catalyst for innovation and positive impact in the Nordic and broader global health tech ecosystem is expected to strengthen[2][3].
